Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).
Christoph W. Reuter
No relevant relationships to disclose
Michael A. Morgan
No relevant relationships to disclose
Christoph von Klot
No relevant relationships to disclose
Axel S. Merseburger
No relevant relationships to disclose
Martin H Fenner
No relevant relationships to disclose
Philipp Ivanyi
No relevant relationships to disclose
Viktor Gruenwald
No relevant relationships to disclose
Arnold Ganser
No relevant relationships to disclose